Sign In
Buy MBX
$48.40
+2.01 (+4.33%)
At Close: Jun 24, 2026
Microbix Biosystems Inc. (MBX:CA) Q1 2026 Earnings Call Transcript
01:54pm, Thursday, 12'th Feb 2026
Microbix Biosystems Inc. (MBX:CA) Q1 2026 Earnings Call Transcript
Microbix Reports Results for Q1 2026
07:20am, Thursday, 12'th Feb 2026
Q1 Revenues of $4.2 million and Controlled Net Loss MISSISSAUGA, ON / ACCESS Newswire / February 12, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix® ), a life sciences innovator, man
MBX Biosciences to Participate in Upcoming Investor Conferences
08:00am, Wednesday, 11'th Feb 2026
CARMEL, Ind., Feb. 11, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel pr
Microbix Biosystems (TSE:MBX) Share Price Passes Below 50-Day Moving Average – Time to Sell?
04:18am, Wednesday, 11'th Feb 2026
Shares of Microbix Biosystems Inc. (TSE: MBX - Get Free Report) passed below its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of C$0.23 and traded as low as C
Microbix Presents Molecular Pathology Platform Results
07:00am, Wednesday, 04'th Feb 2026
Novel Quality Controls to Enable QC & Inter-Laboratory Standardization MISSISSAUGA, ON / ACCESS Newswire / February 4, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix®), a life scienc
Martin Marino Purchases 52,500 Shares of Microbix Biosystems (TSE:MBX) Stock
05:34am, Monday, 26'th Jan 2026
Microbix Biosystems Inc. (TSE: MBX - Get Free Report) Director Martin Marino acquired 52,500 shares of the firm's stock in a transaction on Monday, December 29th. The stock was purchased at an average
MBX Biosciences Appoints Laurie Stelzer to Board of Directors as Audit Committee Chair
08:00am, Thursday, 22'nd Jan 2026
CARMEL, Ind., Jan. 22, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel pre
MBX Biosciences, Inc. (MBX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
02:26pm, Wednesday, 14'th Jan 2026
MBX Biosciences, Inc. (MBX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
MBX Biosciences to Provide 2026 Outlook and Business Update at 44th Annual J.P. Morgan Healthcare Conference
04:00pm, Sunday, 11'th Jan 2026
One-year follow-up data from Phase 2 trial of once-weekly canvuparatide, a potential best-in-class therapy for hypoparathyroidism, anticipated in Q2 2026; Phase 3 initiation on track for Q3 2026 12-we
Microbix Biosystems (TSE:MBX) Shares Cross Below 50-Day Moving Average – Should You Sell?
04:12am, Saturday, 10'th Jan 2026
Microbix Biosystems Inc. (TSE: MBX - Get Free Report)'s share price passed below its 50-day moving average during trading on Friday. The stock has a 50-day moving average of C$0.24 and traded as low a
MBX Biosciences, Inc. (NASDAQ:MBX) Receives Average Recommendation of “Moderate Buy” from Analysts
02:04am, Saturday, 10'th Jan 2026
Shares of MBX Biosciences, Inc. (NASDAQ: MBX - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the thirteen brokerages that are currently covering the stock, MarketBeat R
MBX Biosciences (NASDAQ:MBX) Reaches New 12-Month High – Still a Buy?
04:37am, Thursday, 25'th Dec 2025
Shares of MBX Biosciences, Inc. (NASDAQ: MBX - Get Free Report) hit a new 52-week high during mid-day trading on Tuesday. The stock traded as high as $35.55 and last traded at $34.80, with a volume of
Microbix Biosystems Inc. (MBX:CA) Q4 2025 Earnings Call Transcript
01:47pm, Thursday, 18'th Dec 2025
Microbix Biosystems Inc. (MBX:CA) Q4 2025 Earnings Call Transcript
MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13
08:00am, Monday, 15'th Dec 2025
CARMEL, Ind., Dec. 15, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide ther
This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones
11:10am, Wednesday, 03'rd Dec 2025
Boston-based MPM BioImpact sold 1.3 million shares of MBX Biosciences worth an estimated $14.8 million in the third quarter. The move marked a full exit for MPM BioImpact, which reported holding no sh
